nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—germ cell cancer—uterine cancer	0.67	1	CtDrD
Bleomycin—LIG3—Base Excision Repair—POLD1—uterine cancer	0.00768	0.0497	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH3—uterine cancer	0.00606	0.0392	CbGpPWpGaD
Bleomycin—LIG1—MMR—MSH3—uterine cancer	0.00575	0.0372	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MSH6—uterine cancer	0.00549	0.0355	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—POLD1—uterine cancer	0.00542	0.0351	CbGpPWpGaD
Bleomycin—LIG3—epithelium—uterine cancer	0.00451	0.058	CbGeAlD
Bleomycin—LIG3—uterine cervix—uterine cancer	0.00447	0.0575	CbGeAlD
Bleomycin—LIG1—Mismatch repair—MSH2—uterine cancer	0.00445	0.0288	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PMS2—uterine cancer	0.0044	0.0285	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PMS2—uterine cancer	0.0044	0.0285	CbGpPWpGaD
Bleomycin—LIG1—Processive synthesis on the C-strand of the telomere—POLD1—uterine cancer	0.00431	0.0279	CbGpPWpGaD
Bleomycin—BLMH—myometrium—uterine cancer	0.00429	0.0552	CbGeAlD
Bleomycin—LIG3—renal system—uterine cancer	0.00418	0.0538	CbGeAlD
Bleomycin—LIG1—MMR—PMS2—uterine cancer	0.00418	0.027	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MLH1—uterine cancer	0.00401	0.026	CbGpPWpGaD
Bleomycin—LIG1—endometrium—uterine cancer	0.00374	0.0481	CbGeAlD
Bleomycin—LIG3—uterus—uterine cancer	0.00372	0.0479	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH6—uterine cancer	0.00365	0.0236	CbGpPWpGaD
Bleomycin—LIG1—mammalian vulva—uterine cancer	0.00362	0.0465	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—POLD1—uterine cancer	0.0036	0.0233	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—POLD1—uterine cancer	0.0036	0.0233	CbGpPWpGaD
Bleomycin—LIG1—MMR—MSH6—uterine cancer	0.00346	0.0224	CbGpPWpGaD
Bleomycin—LIG1—uterus—uterine cancer	0.00345	0.0443	CbGeAlD
Bleomycin—LIG1—MMR—POLD1—uterine cancer	0.00342	0.0221	CbGpPWpGaD
Bleomycin—LIG1—Processive synthesis on the lagging strand—POLD1—uterine cancer	0.00342	0.0221	CbGpPWpGaD
Bleomycin—LIG3—female reproductive system—uterine cancer	0.00335	0.0431	CbGeAlD
Bleomycin—BLMH—uterine cervix—uterine cancer	0.00334	0.0429	CbGeAlD
Bleomycin—LIG1—Removal of DNA patch containing abasic residue—POLD1—uterine cancer	0.00326	0.0211	CbGpPWpGaD
Bleomycin—LIG1—Gap-filling DNA repair synthesis and ligation in GG-NER—POLD1—uterine cancer	0.00326	0.0211	CbGpPWpGaD
Bleomycin—BLMH—decidua—uterine cancer	0.00318	0.0409	CbGeAlD
Bleomycin—BLMH—renal system—uterine cancer	0.00312	0.0402	CbGeAlD
Bleomycin—LIG3—DNA Repair—MSH3—uterine cancer	0.0031	0.0201	CbGpPWpGaD
Bleomycin—LIG1—female reproductive system—uterine cancer	0.0031	0.0398	CbGeAlD
Bleomycin—LIG3—female gonad—uterine cancer	0.00305	0.0392	CbGeAlD
Bleomycin—BLMH—endometrium—uterine cancer	0.00302	0.0388	CbGeAlD
Bleomycin—LIG1—Base Excision Repair—POLD1—uterine cancer	0.00298	0.0193	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—uterine cancer	0.00296	0.0191	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—uterine cancer	0.00296	0.0191	CbGpPWpGaD
Bleomycin—BLMH—mammalian vulva—uterine cancer	0.00292	0.0376	CbGeAlD
Bleomycin—LIG1—female gonad—uterine cancer	0.00282	0.0362	CbGeAlD
Bleomycin—LIG1—MMR—MSH2—uterine cancer	0.00281	0.0182	CbGpPWpGaD
Bleomycin—LIG1—vagina—uterine cancer	0.0028	0.036	CbGeAlD
Bleomycin—BLMH—uterus—uterine cancer	0.00278	0.0358	CbGeAlD
Bleomycin—LIG1—Lagging Strand Synthesis—POLD1—uterine cancer	0.00275	0.0178	CbGpPWpGaD
Bleomycin—LIG1—Early Phase of HIV Life Cycle—HMGA1—uterine cancer	0.00267	0.0173	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MLH1—uterine cancer	0.00267	0.0172	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MLH1—uterine cancer	0.00267	0.0172	CbGpPWpGaD
Bleomycin—LIG1—Telomere C-strand (Lagging Strand) Synthesis—POLD1—uterine cancer	0.00256	0.0165	CbGpPWpGaD
Bleomycin—LIG1—MMR—MLH1—uterine cancer	0.00253	0.0164	CbGpPWpGaD
Bleomycin—BLMH—female reproductive system—uterine cancer	0.0025	0.0322	CbGeAlD
Bleomycin—BLMH—female gonad—uterine cancer	0.00228	0.0293	CbGeAlD
Bleomycin—BLMH—vagina—uterine cancer	0.00226	0.0291	CbGeAlD
Bleomycin—LIG3—DNA Repair—PMS2—uterine cancer	0.00226	0.0146	CbGpPWpGaD
Bleomycin—LIG1—Extension of Telomeres—POLD1—uterine cancer	0.00213	0.0137	CbGpPWpGaD
Bleomycin—LIG1—DNA strand elongation—POLD1—uterine cancer	0.00196	0.0127	CbGpPWpGaD
Bleomycin—LIG3—lymph node—uterine cancer	0.00196	0.0252	CbGeAlD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—POLD1—uterine cancer	0.00187	0.0121	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—MSH6—uterine cancer	0.00187	0.0121	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—POLD1—uterine cancer	0.00185	0.0119	CbGpPWpGaD
Bleomycin—LIG1—lymph node—uterine cancer	0.00181	0.0233	CbGeAlD
Bleomycin—LIG3—DNA Repair—MSH2—uterine cancer	0.00152	0.0098	CbGpPWpGaD
Bleomycin—LIG1—Transcription-coupled NER (TC-NER)—POLD1—uterine cancer	0.0015	0.00967	CbGpPWpGaD
Bleomycin—BLMH—lymph node—uterine cancer	0.00146	0.0188	CbGeAlD
Bleomycin—LIG1—Nucleotide Excision Repair—POLD1—uterine cancer	0.00137	0.00889	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—MLH1—uterine cancer	0.00137	0.00884	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—MSH3—uterine cancer	0.0012	0.00779	CbGpPWpGaD
Bleomycin—LIG1—Telomere Maintenance—POLD1—uterine cancer	0.000963	0.00623	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000875	0.00566	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—PMS2—uterine cancer	0.000875	0.00566	CbGpPWpGaD
Bleomycin—LIG1—Synthesis of DNA—POLD1—uterine cancer	0.000816	0.00528	CbGpPWpGaD
Bleomycin—LIG1—Chromosome Maintenance—POLD1—uterine cancer	0.000802	0.00519	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—POLD1—uterine cancer	0.000765	0.00495	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—MSH6—uterine cancer	0.000725	0.00469	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—POLD1—uterine cancer	0.000716	0.00463	CbGpPWpGaD
Bleomycin—LIG1—S Phase—POLD1—uterine cancer	0.000669	0.00433	CbGpPWpGaD
Bleomycin—LIG1—Podofilox—Etoposide—uterine cancer	0.000652	0.152	CbGdCrCtD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—FBXW7—uterine cancer	0.000648	0.00419	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—MSH2—uterine cancer	0.000588	0.0038	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—FBXW7—uterine cancer	0.000556	0.0036	CbGpPWpGaD
Bleomycin—LIG1—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000532	0.124	CbGdCrCtD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—SOCS3—uterine cancer	0.00053	0.00343	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—MLH1—uterine cancer	0.00053	0.00343	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000489	0.00316	CbGpPWpGaD
Bleomycin—Ulcer—Etoposide—uterine cancer	0.000481	0.00517	CcSEcCtD
Bleomycin—Body temperature increased—Carboplatin—uterine cancer	0.000477	0.00514	CcSEcCtD
Bleomycin—LIG1—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.000474	0.111	CbGdCrCtD
Bleomycin—LIG1—Methyltestosterone—Progesterone—uterine cancer	0.000464	0.108	CbGdCrCtD
Bleomycin—LIG1—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.000463	0.108	CbGdCrCtD
Bleomycin—Mucosal inflammation—Epirubicin—uterine cancer	0.00046	0.00495	CcSEcCtD
Bleomycin—Local reaction—Epirubicin—uterine cancer	0.00046	0.00495	CcSEcCtD
Bleomycin—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.000457	0.00492	CcSEcCtD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—SOCS3—uterine cancer	0.000455	0.00294	CbGpPWpGaD
Bleomycin—Haemoglobin—Progesterone—uterine cancer	0.000448	0.00483	CcSEcCtD
Bleomycin—Haemorrhage—Progesterone—uterine cancer	0.000446	0.0048	CcSEcCtD
Bleomycin—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.00478	CcSEcCtD
Bleomycin—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.000442	0.00475	CcSEcCtD
Bleomycin—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.000439	0.00473	CcSEcCtD
Bleomycin—Skin exfoliation—Etoposide—uterine cancer	0.000434	0.00467	CcSEcCtD
Bleomycin—LIG1—HIV Life Cycle—HMGA1—uterine cancer	0.000433	0.0028	CbGpPWpGaD
Bleomycin—Skin hyperpigmentation—Epirubicin—uterine cancer	0.000428	0.00461	CcSEcCtD
Bleomycin—Local reaction—Doxorubicin—uterine cancer	0.000426	0.00458	CcSEcCtD
Bleomycin—Mucosal inflammation—Doxorubicin—uterine cancer	0.000426	0.00458	CcSEcCtD
Bleomycin—Febrile neutropenia—Epirubicin—uterine cancer	0.000424	0.00456	CcSEcCtD
Bleomycin—LIG1—Testosterone—Progesterone—uterine cancer	0.000413	0.0966	CbGdCrCtD
Bleomycin—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000406	0.00438	CcSEcCtD
Bleomycin—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000404	0.00435	CcSEcCtD
Bleomycin—LIG1—Testosterone Propionate—Progesterone—uterine cancer	0.000404	0.0943	CbGdCrCtD
Bleomycin—Hypomagnesaemia—Epirubicin—uterine cancer	0.000401	0.00432	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Doxorubicin—uterine cancer	0.000396	0.00427	CcSEcCtD
Bleomycin—Alopecia—Progesterone—uterine cancer	0.000394	0.00424	CcSEcCtD
Bleomycin—Nail disorder—Epirubicin—uterine cancer	0.000393	0.00423	CcSEcCtD
Bleomycin—Febrile neutropenia—Doxorubicin—uterine cancer	0.000392	0.00422	CcSEcCtD
Bleomycin—Erythema—Progesterone—uterine cancer	0.000388	0.00418	CcSEcCtD
Bleomycin—Phlebitis—Etoposide—uterine cancer	0.000383	0.00412	CcSEcCtD
Bleomycin—Pancytopenia—Dactinomycin—uterine cancer	0.000374	0.00403	CcSEcCtD
Bleomycin—Hypomagnesaemia—Doxorubicin—uterine cancer	0.000371	0.004	CcSEcCtD
Bleomycin—Nail disorder—Doxorubicin—uterine cancer	0.000364	0.00391	CcSEcCtD
Bleomycin—Chills—Medroxyprogesterone Acetate—uterine cancer	0.000363	0.00391	CcSEcCtD
Bleomycin—Ill-defined disorder—Progesterone—uterine cancer	0.00036	0.00388	CcSEcCtD
Bleomycin—Anaemia—Progesterone—uterine cancer	0.000359	0.00387	CcSEcCtD
Bleomycin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.00385	CcSEcCtD
Bleomycin—Pneumonia—Dactinomycin—uterine cancer	0.000353	0.0038	CcSEcCtD
Bleomycin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000352	0.00379	CcSEcCtD
Bleomycin—Malaise—Progesterone—uterine cancer	0.00035	0.00377	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MLH3—uterine cancer	0.000342	0.00222	CbGpPWpGaD
Bleomycin—Stomatitis—Dactinomycin—uterine cancer	0.000342	0.00369	CcSEcCtD
Bleomycin—Cough—Progesterone—uterine cancer	0.000339	0.00365	CcSEcCtD
Bleomycin—LIG1—Danazol—Progesterone—uterine cancer	0.000336	0.0784	CbGdCrCtD
Bleomycin—Myalgia—Progesterone—uterine cancer	0.000331	0.00356	CcSEcCtD
Bleomycin—Chest pain—Progesterone—uterine cancer	0.000331	0.00356	CcSEcCtD
Bleomycin—Discomfort—Progesterone—uterine cancer	0.000327	0.00352	CcSEcCtD
Bleomycin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000327	0.00352	CcSEcCtD
Bleomycin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000325	0.0035	CcSEcCtD
Bleomycin—Hyperaesthesia—Epirubicin—uterine cancer	0.000325	0.00349	CcSEcCtD
Bleomycin—Confusional state—Progesterone—uterine cancer	0.00032	0.00344	CcSEcCtD
Bleomycin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000317	0.00342	CcSEcCtD
Bleomycin—Anaphylactic shock—Progesterone—uterine cancer	0.000317	0.00341	CcSEcCtD
Bleomycin—Oedema—Progesterone—uterine cancer	0.000317	0.00341	CcSEcCtD
Bleomycin—Infection—Progesterone—uterine cancer	0.000315	0.00339	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000314	0.00203	CbGpPWpGaD
Bleomycin—LIG1—Norethindrone—Progesterone—uterine cancer	0.000302	0.0706	CbGdCrCtD
Bleomycin—Anorexia—Progesterone—uterine cancer	0.000302	0.00325	CcSEcCtD
Bleomycin—Hyperaesthesia—Doxorubicin—uterine cancer	0.0003	0.00323	CcSEcCtD
Bleomycin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.0003	0.00323	CcSEcCtD
Bleomycin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.0003	0.00323	CcSEcCtD
Bleomycin—LIG1—HIV Infection—HMGA1—uterine cancer	0.000299	0.00194	CbGpPWpGaD
Bleomycin—Hypotension—Progesterone—uterine cancer	0.000296	0.00319	CcSEcCtD
Bleomycin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000296	0.00319	CcSEcCtD
Bleomycin—Flushing—Dactinomycin—uterine cancer	0.000293	0.00315	CcSEcCtD
Bleomycin—Extravasation—Epirubicin—uterine cancer	0.000292	0.00314	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000291	0.00188	CbGpPWpGaD
Bleomycin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00029	0.00312	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000289	0.00311	CcSEcCtD
Bleomycin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00309	CcSEcCtD
Bleomycin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00309	CcSEcCtD
Bleomycin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00307	CcSEcCtD
Bleomycin—Paraesthesia—Progesterone—uterine cancer	0.000285	0.00306	CcSEcCtD
Bleomycin—Chills—Dactinomycin—uterine cancer	0.000283	0.00305	CcSEcCtD
Bleomycin—Dyspnoea—Progesterone—uterine cancer	0.000283	0.00304	CcSEcCtD
Bleomycin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000281	0.00303	CcSEcCtD
Bleomycin—Bronchospasm—Etoposide—uterine cancer	0.000281	0.00302	CcSEcCtD
Bleomycin—Alopecia—Dactinomycin—uterine cancer	0.000279	0.003	CcSEcCtD
Bleomycin—Decreased appetite—Progesterone—uterine cancer	0.000276	0.00297	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FBXW7—uterine cancer	0.000275	0.00178	CbGpPWpGaD
Bleomycin—Erythema—Dactinomycin—uterine cancer	0.000275	0.00296	CcSEcCtD
Bleomycin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000274	0.00295	CcSEcCtD
Bleomycin—Pain—Progesterone—uterine cancer	0.000271	0.00292	CcSEcCtD
Bleomycin—Pancytopenia—Etoposide—uterine cancer	0.000271	0.00292	CcSEcCtD
Bleomycin—Extravasation—Doxorubicin—uterine cancer	0.00027	0.00291	CcSEcCtD
Bleomycin—Ulcer—Epirubicin—uterine cancer	0.000269	0.0029	CcSEcCtD
Bleomycin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000268	0.00289	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000268	0.00173	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000264	0.00171	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000262	0.00282	CcSEcCtD
Bleomycin—Feeling abnormal—Progesterone—uterine cancer	0.000261	0.00281	CcSEcCtD
Bleomycin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000258	0.00278	CcSEcCtD
Bleomycin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000256	0.00276	CcSEcCtD
Bleomycin—Pneumonia—Etoposide—uterine cancer	0.000256	0.00275	CcSEcCtD
Bleomycin—Ill-defined disorder—Dactinomycin—uterine cancer	0.000255	0.00274	CcSEcCtD
Bleomycin—Anaemia—Dactinomycin—uterine cancer	0.000254	0.00273	CcSEcCtD
Bleomycin—Urticaria—Progesterone—uterine cancer	0.000252	0.00271	CcSEcCtD
Bleomycin—Acute coronary syndrome—Etoposide—uterine cancer	0.000251	0.0027	CcSEcCtD
Bleomycin—Body temperature increased—Progesterone—uterine cancer	0.000251	0.0027	CcSEcCtD
Bleomycin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00025	0.00269	CcSEcCtD
Bleomycin—Ulcer—Doxorubicin—uterine cancer	0.000249	0.00268	CcSEcCtD
Bleomycin—Myocardial infarction—Etoposide—uterine cancer	0.000249	0.00268	CcSEcCtD
Bleomycin—Cystitis noninfective—Epirubicin—uterine cancer	0.000249	0.00268	CcSEcCtD
Bleomycin—Stomatitis—Etoposide—uterine cancer	0.000248	0.00267	CcSEcCtD
Bleomycin—Malaise—Dactinomycin—uterine cancer	0.000248	0.00267	CcSEcCtD
Bleomycin—Cystitis—Epirubicin—uterine cancer	0.000246	0.00265	CcSEcCtD
Bleomycin—Leukopenia—Dactinomycin—uterine cancer	0.000246	0.00265	CcSEcCtD
Bleomycin—Skin exfoliation—Epirubicin—uterine cancer	0.000243	0.00262	CcSEcCtD
Bleomycin—LIG1—Levonorgestrel—Progesterone—uterine cancer	0.000241	0.0562	CbGdCrCtD
Bleomycin—LIG1—Cell Cycle—NDC80—uterine cancer	0.00024	0.00155	CbGpPWpGaD
Bleomycin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.00255	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000237	0.00153	CbGpPWpGaD
Bleomycin—Myalgia—Dactinomycin—uterine cancer	0.000234	0.00252	CcSEcCtD
Bleomycin—Hypersensitivity—Progesterone—uterine cancer	0.000234	0.00251	CcSEcCtD
Bleomycin—Discomfort—Dactinomycin—uterine cancer	0.000231	0.00249	CcSEcCtD
Bleomycin—Bladder pain—Epirubicin—uterine cancer	0.00023	0.00248	CcSEcCtD
Bleomycin—Cystitis noninfective—Doxorubicin—uterine cancer	0.00023	0.00248	CcSEcCtD
Bleomycin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000228	0.00246	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000228	0.00147	CbGpPWpGaD
Bleomycin—Cystitis—Doxorubicin—uterine cancer	0.000228	0.00245	CcSEcCtD
Bleomycin—Asthenia—Progesterone—uterine cancer	0.000227	0.00245	CcSEcCtD
Bleomycin—Hypoaesthesia—Etoposide—uterine cancer	0.000227	0.00245	CcSEcCtD
Bleomycin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000227	0.00244	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—SOCS3—uterine cancer	0.000225	0.00146	CbGpPWpGaD
Bleomycin—Skin exfoliation—Doxorubicin—uterine cancer	0.000225	0.00242	CcSEcCtD
Bleomycin—Pruritus—Progesterone—uterine cancer	0.000224	0.00241	CcSEcCtD
Bleomycin—Oedema—Dactinomycin—uterine cancer	0.000224	0.00241	CcSEcCtD
Bleomycin—Infection—Dactinomycin—uterine cancer	0.000223	0.0024	CcSEcCtD
Bleomycin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000219	0.00236	CcSEcCtD
Bleomycin—Phlebitis—Epirubicin—uterine cancer	0.000215	0.00231	CcSEcCtD
Bleomycin—Anorexia—Dactinomycin—uterine cancer	0.000214	0.0023	CcSEcCtD
Bleomycin—Bladder pain—Doxorubicin—uterine cancer	0.000213	0.00229	CcSEcCtD
Bleomycin—Flushing—Etoposide—uterine cancer	0.000212	0.00228	CcSEcCtD
Bleomycin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.00228	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—CDKN1B—uterine cancer	0.000208	0.00134	CbGpPWpGaD
Bleomycin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.00222	CcSEcCtD
Bleomycin—Chills—Etoposide—uterine cancer	0.000205	0.0022	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000204	0.0022	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—POLD1—uterine cancer	0.000204	0.00132	CbGpPWpGaD
Bleomycin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000203	0.00219	CcSEcCtD
Bleomycin—Alopecia—Etoposide—uterine cancer	0.000202	0.00217	CcSEcCtD
Bleomycin—Vomiting—Progesterone—uterine cancer	0.000202	0.00217	CcSEcCtD
Bleomycin—Rash—Progesterone—uterine cancer	0.0002	0.00215	CcSEcCtD
Bleomycin—Dermatitis—Progesterone—uterine cancer	0.0002	0.00215	CcSEcCtD
Bleomycin—Phlebitis—Doxorubicin—uterine cancer	0.000199	0.00214	CcSEcCtD
Bleomycin—LIG1—DNA Replication—CDKN1B—uterine cancer	0.000195	0.00126	CbGpPWpGaD
Bleomycin—Decreased appetite—Dactinomycin—uterine cancer	0.000195	0.0021	CcSEcCtD
Bleomycin—Pain—Dactinomycin—uterine cancer	0.000192	0.00206	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—RRM2—uterine cancer	0.00019	0.00123	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Epirubicin—uterine cancer	0.000189	0.00203	CcSEcCtD
Bleomycin—Nausea—Progesterone—uterine cancer	0.000188	0.00203	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FGFR2—uterine cancer	0.000188	0.00121	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IRF1—uterine cancer	0.000186	0.0012	CbGpPWpGaD
Bleomycin—Feeling abnormal—Dactinomycin—uterine cancer	0.000185	0.00199	CcSEcCtD
Bleomycin—Ill-defined disorder—Etoposide—uterine cancer	0.000184	0.00198	CcSEcCtD
Bleomycin—Anaemia—Etoposide—uterine cancer	0.000184	0.00198	CcSEcCtD
Bleomycin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000183	0.00197	CcSEcCtD
Bleomycin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00195	CcSEcCtD
Bleomycin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00195	CcSEcCtD
Bleomycin—Malaise—Etoposide—uterine cancer	0.000179	0.00193	CcSEcCtD
Bleomycin—Leukopenia—Etoposide—uterine cancer	0.000178	0.00191	CcSEcCtD
Bleomycin—Body temperature increased—Dactinomycin—uterine cancer	0.000177	0.00191	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000176	0.00114	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000175	0.00188	CcSEcCtD
Bleomycin—Cough—Etoposide—uterine cancer	0.000173	0.00187	CcSEcCtD
Bleomycin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00184	CcSEcCtD
Bleomycin—LIG1—S Phase—CDKN1B—uterine cancer	0.00017	0.0011	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—RRM2—uterine cancer	0.00017	0.0011	CbGpPWpGaD
Bleomycin—Chest pain—Etoposide—uterine cancer	0.000169	0.00182	CcSEcCtD
Bleomycin—Discomfort—Etoposide—uterine cancer	0.000167	0.0018	CcSEcCtD
Bleomycin—BLMH—Immune System—FBXW7—uterine cancer	0.000167	0.00108	CbGpPWpGaD
Bleomycin—Hypersensitivity—Dactinomycin—uterine cancer	0.000165	0.00178	CcSEcCtD
Bleomycin—Confusional state—Etoposide—uterine cancer	0.000164	0.00176	CcSEcCtD
Bleomycin—Anaphylactic shock—Etoposide—uterine cancer	0.000162	0.00175	CcSEcCtD
Bleomycin—Infection—Etoposide—uterine cancer	0.000161	0.00173	CcSEcCtD
Bleomycin—Asthenia—Dactinomycin—uterine cancer	0.000161	0.00173	CcSEcCtD
Bleomycin—Thrombocytopenia—Etoposide—uterine cancer	0.000159	0.00171	CcSEcCtD
Bleomycin—Anorexia—Etoposide—uterine cancer	0.000155	0.00166	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000152	0.000986	CbGpPWpGaD
Bleomycin—Pancytopenia—Epirubicin—uterine cancer	0.000152	0.00163	CcSEcCtD
Bleomycin—Hypotension—Etoposide—uterine cancer	0.000152	0.00163	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MLH1—uterine cancer	0.000151	0.000975	CbGpPWpGaD
Bleomycin—Paraesthesia—Etoposide—uterine cancer	0.000146	0.00157	CcSEcCtD
Bleomycin—Weight decreased—Epirubicin—uterine cancer	0.000145	0.00156	CcSEcCtD
Bleomycin—Dyspnoea—Etoposide—uterine cancer	0.000145	0.00156	CcSEcCtD
Bleomycin—Pneumonia—Epirubicin—uterine cancer	0.000143	0.00154	CcSEcCtD
Bleomycin—LIG1—Disease—AKR1B10—uterine cancer	0.000143	0.000926	CbGpPWpGaD
Bleomycin—Vomiting—Dactinomycin—uterine cancer	0.000142	0.00153	CcSEcCtD
Bleomycin—Rash—Dactinomycin—uterine cancer	0.000141	0.00152	CcSEcCtD
Bleomycin—Decreased appetite—Etoposide—uterine cancer	0.000141	0.00152	CcSEcCtD
Bleomycin—Pancytopenia—Doxorubicin—uterine cancer	0.00014	0.00151	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDH1—uterine cancer	0.00014	0.000904	CbGpPWpGaD
Bleomycin—Stomatitis—Epirubicin—uterine cancer	0.000139	0.0015	CcSEcCtD
Bleomycin—Pain—Etoposide—uterine cancer	0.000139	0.00149	CcSEcCtD
Bleomycin—BLMH—Immune System—SOCS3—uterine cancer	0.000137	0.000883	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—YWHAE—uterine cancer	0.000136	0.000882	CbGpPWpGaD
Bleomycin—Haematuria—Epirubicin—uterine cancer	0.000136	0.00146	CcSEcCtD
Bleomycin—Weight decreased—Doxorubicin—uterine cancer	0.000134	0.00144	CcSEcCtD
Bleomycin—Feeling abnormal—Etoposide—uterine cancer	0.000134	0.00144	CcSEcCtD
Bleomycin—Nausea—Dactinomycin—uterine cancer	0.000133	0.00143	CcSEcCtD
Bleomycin—Pneumonia—Doxorubicin—uterine cancer	0.000133	0.00143	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000129	0.000837	CbGpPWpGaD
Bleomycin—Urticaria—Etoposide—uterine cancer	0.000129	0.00139	CcSEcCtD
Bleomycin—Haemoglobin—Epirubicin—uterine cancer	0.000129	0.00138	CcSEcCtD
Bleomycin—Stomatitis—Doxorubicin—uterine cancer	0.000129	0.00138	CcSEcCtD
Bleomycin—Body temperature increased—Etoposide—uterine cancer	0.000128	0.00138	CcSEcCtD
Bleomycin—Haemorrhage—Epirubicin—uterine cancer	0.000128	0.00138	CcSEcCtD
Bleomycin—Hypoaesthesia—Epirubicin—uterine cancer	0.000127	0.00137	CcSEcCtD
Bleomycin—Haematuria—Doxorubicin—uterine cancer	0.000126	0.00135	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00012	0.000775	CbGpPWpGaD
Bleomycin—Hypersensitivity—Etoposide—uterine cancer	0.000119	0.00129	CcSEcCtD
Bleomycin—Haemoglobin—Doxorubicin—uterine cancer	0.000119	0.00128	CcSEcCtD
Bleomycin—Flushing—Epirubicin—uterine cancer	0.000119	0.00128	CcSEcCtD
Bleomycin—LIG1—Disease—RNF43—uterine cancer	0.000119	0.000768	CbGpPWpGaD
Bleomycin—Haemorrhage—Doxorubicin—uterine cancer	0.000118	0.00127	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—ERBB2—uterine cancer	0.000118	0.000762	CbGpPWpGaD
Bleomycin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000118	0.00127	CcSEcCtD
Bleomycin—Asthenia—Etoposide—uterine cancer	0.000116	0.00125	CcSEcCtD
Bleomycin—Chills—Epirubicin—uterine cancer	0.000115	0.00124	CcSEcCtD
Bleomycin—Pruritus—Etoposide—uterine cancer	0.000115	0.00124	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000115	0.000741	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FGFR2—uterine cancer	0.000114	0.000736	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000113	0.000732	CbGpPWpGaD
Bleomycin—Alopecia—Epirubicin—uterine cancer	0.000113	0.00122	CcSEcCtD
Bleomycin—Erythema—Epirubicin—uterine cancer	0.000111	0.0012	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.00011	0.000714	CbGpPWpGaD
Bleomycin—Flushing—Doxorubicin—uterine cancer	0.00011	0.00118	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDKN1B—uterine cancer	0.000109	0.000706	CbGpPWpGaD
Bleomycin—Chills—Doxorubicin—uterine cancer	0.000106	0.00114	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000105	0.000681	CbGpPWpGaD
Bleomycin—Alopecia—Doxorubicin—uterine cancer	0.000105	0.00113	CcSEcCtD
Bleomycin—Ill-defined disorder—Epirubicin—uterine cancer	0.000103	0.00111	CcSEcCtD
Bleomycin—Vomiting—Etoposide—uterine cancer	0.000103	0.00111	CcSEcCtD
Bleomycin—Erythema—Doxorubicin—uterine cancer	0.000103	0.00111	CcSEcCtD
Bleomycin—Anaemia—Epirubicin—uterine cancer	0.000103	0.00111	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDKN2B—uterine cancer	0.000102	0.000662	CbGpPWpGaD
Bleomycin—Rash—Etoposide—uterine cancer	0.000102	0.0011	CcSEcCtD
Bleomycin—Dermatitis—Etoposide—uterine cancer	0.000102	0.0011	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PTEN—uterine cancer	0.000101	0.00065	CbGpPWpGaD
Bleomycin—Malaise—Epirubicin—uterine cancer	0.0001	0.00108	CcSEcCtD
Bleomycin—Leukopenia—Epirubicin—uterine cancer	9.97e-05	0.00107	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.97e-05	0.000645	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—BIRC5—uterine cancer	9.88e-05	0.000639	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKR1C1—uterine cancer	9.77e-05	0.000632	CbGpPWpGaD
Bleomycin—Cough—Epirubicin—uterine cancer	9.72e-05	0.00105	CcSEcCtD
Bleomycin—Nausea—Etoposide—uterine cancer	9.63e-05	0.00104	CcSEcCtD
Bleomycin—Ill-defined disorder—Doxorubicin—uterine cancer	9.56e-05	0.00103	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—uterine cancer	9.53e-05	0.00103	CcSEcCtD
Bleomycin—Myalgia—Epirubicin—uterine cancer	9.48e-05	0.00102	CcSEcCtD
Bleomycin—Chest pain—Epirubicin—uterine cancer	9.48e-05	0.00102	CcSEcCtD
Bleomycin—Discomfort—Epirubicin—uterine cancer	9.37e-05	0.00101	CcSEcCtD
Bleomycin—Malaise—Doxorubicin—uterine cancer	9.29e-05	0.001	CcSEcCtD
Bleomycin—Leukopenia—Doxorubicin—uterine cancer	9.23e-05	0.000993	CcSEcCtD
Bleomycin—Confusional state—Epirubicin—uterine cancer	9.17e-05	0.000987	CcSEcCtD
Bleomycin—Oedema—Epirubicin—uterine cancer	9.09e-05	0.000979	CcSEcCtD
Bleomycin—Anaphylactic shock—Epirubicin—uterine cancer	9.09e-05	0.000979	CcSEcCtD
Bleomycin—Infection—Epirubicin—uterine cancer	9.03e-05	0.000972	CcSEcCtD
Bleomycin—Cough—Doxorubicin—uterine cancer	8.99e-05	0.000968	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—NRAS—uterine cancer	8.97e-05	0.00058	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Epirubicin—uterine cancer	8.9e-05	0.000958	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—BIRC5—uterine cancer	8.84e-05	0.000572	CbGpPWpGaD
Bleomycin—Myalgia—Doxorubicin—uterine cancer	8.77e-05	0.000945	CcSEcCtD
Bleomycin—Chest pain—Doxorubicin—uterine cancer	8.77e-05	0.000945	CcSEcCtD
Bleomycin—Discomfort—Doxorubicin—uterine cancer	8.67e-05	0.000933	CcSEcCtD
Bleomycin—Anorexia—Epirubicin—uterine cancer	8.67e-05	0.000933	CcSEcCtD
Bleomycin—Hypotension—Epirubicin—uterine cancer	8.49e-05	0.000914	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—uterine cancer	8.48e-05	0.000913	CcSEcCtD
Bleomycin—BLMH—Immune System—CDH1—uterine cancer	8.47e-05	0.000548	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	8.47e-05	0.000548	CbGpPWpGaD
Bleomycin—LIG1—Disease—DCN—uterine cancer	8.46e-05	0.000547	CbGpPWpGaD
Bleomycin—Oedema—Doxorubicin—uterine cancer	8.41e-05	0.000906	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—uterine cancer	8.41e-05	0.000906	CcSEcCtD
Bleomycin—Infection—Doxorubicin—uterine cancer	8.36e-05	0.0009	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Epirubicin—uterine cancer	8.28e-05	0.000892	CcSEcCtD
Bleomycin—Thrombocytopenia—Doxorubicin—uterine cancer	8.24e-05	0.000887	CcSEcCtD
Bleomycin—Paraesthesia—Epirubicin—uterine cancer	8.16e-05	0.000879	CcSEcCtD
Bleomycin—Dyspnoea—Epirubicin—uterine cancer	8.1e-05	0.000873	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—uterine cancer	8.02e-05	0.000863	CcSEcCtD
Bleomycin—Decreased appetite—Epirubicin—uterine cancer	7.9e-05	0.000851	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—uterine cancer	7.86e-05	0.000846	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.78e-05	0.000504	CbGpPWpGaD
Bleomycin—Pain—Epirubicin—uterine cancer	7.77e-05	0.000837	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KRAS—uterine cancer	7.72e-05	0.000499	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	7.66e-05	0.000825	CcSEcCtD
Bleomycin—Paraesthesia—Doxorubicin—uterine cancer	7.55e-05	0.000813	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.53e-05	0.000487	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKR1C3—uterine cancer	7.52e-05	0.000487	CbGpPWpGaD
Bleomycin—Dyspnoea—Doxorubicin—uterine cancer	7.5e-05	0.000807	CcSEcCtD
Bleomycin—Feeling abnormal—Epirubicin—uterine cancer	7.49e-05	0.000806	CcSEcCtD
Bleomycin—LIG1—Disease—HMGA1—uterine cancer	7.33e-05	0.000474	CbGpPWpGaD
Bleomycin—Decreased appetite—Doxorubicin—uterine cancer	7.31e-05	0.000787	CcSEcCtD
Bleomycin—Urticaria—Epirubicin—uterine cancer	7.22e-05	0.000777	CcSEcCtD
Bleomycin—Pain—Doxorubicin—uterine cancer	7.19e-05	0.000774	CcSEcCtD
Bleomycin—Body temperature increased—Epirubicin—uterine cancer	7.19e-05	0.000774	CcSEcCtD
Bleomycin—BLMH—Immune System—ERBB2—uterine cancer	7.15e-05	0.000462	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CA—uterine cancer	7.09e-05	0.000459	CbGpPWpGaD
Bleomycin—Feeling abnormal—Doxorubicin—uterine cancer	6.93e-05	0.000746	CcSEcCtD
Bleomycin—LIG1—Disease—FBXW7—uterine cancer	6.71e-05	0.000434	CbGpPWpGaD
Bleomycin—Hypersensitivity—Epirubicin—uterine cancer	6.7e-05	0.000721	CcSEcCtD
Bleomycin—Urticaria—Doxorubicin—uterine cancer	6.68e-05	0.000719	CcSEcCtD
Bleomycin—Body temperature increased—Doxorubicin—uterine cancer	6.65e-05	0.000716	CcSEcCtD
Bleomycin—BLMH—Immune System—CDKN1B—uterine cancer	6.62e-05	0.000428	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HRAS—uterine cancer	6.56e-05	0.000424	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	6.55e-05	0.000424	CbGpPWpGaD
Bleomycin—Asthenia—Epirubicin—uterine cancer	6.52e-05	0.000702	CcSEcCtD
Bleomycin—Pruritus—Epirubicin—uterine cancer	6.43e-05	0.000692	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.36e-05	0.000411	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CTNNB1—uterine cancer	6.26e-05	0.000405	CbGpPWpGaD
Bleomycin—Hypersensitivity—Doxorubicin—uterine cancer	6.2e-05	0.000667	CcSEcCtD
Bleomycin—BLMH—Immune System—PTEN—uterine cancer	6.1e-05	0.000394	CbGpPWpGaD
Bleomycin—Asthenia—Doxorubicin—uterine cancer	6.04e-05	0.00065	CcSEcCtD
Bleomycin—Pruritus—Doxorubicin—uterine cancer	5.95e-05	0.000641	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDKN2A—uterine cancer	5.86e-05	0.000379	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EP300—uterine cancer	5.81e-05	0.000376	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	5.8e-05	0.000375	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—AKT1—uterine cancer	5.79e-05	0.000375	CbGpPWpGaD
Bleomycin—Vomiting—Epirubicin—uterine cancer	5.78e-05	0.000622	CcSEcCtD
Bleomycin—Rash—Epirubicin—uterine cancer	5.73e-05	0.000617	CcSEcCtD
Bleomycin—Dermatitis—Epirubicin—uterine cancer	5.73e-05	0.000616	CcSEcCtD
Bleomycin—BLMH—Immune System—NRAS—uterine cancer	5.44e-05	0.000352	CbGpPWpGaD
Bleomycin—Nausea—Epirubicin—uterine cancer	5.4e-05	0.000581	CcSEcCtD
Bleomycin—Vomiting—Doxorubicin—uterine cancer	5.35e-05	0.000576	CcSEcCtD
Bleomycin—Rash—Doxorubicin—uterine cancer	5.3e-05	0.000571	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—uterine cancer	5.3e-05	0.00057	CcSEcCtD
Bleomycin—LIG1—Disease—CDKN2B—uterine cancer	5.25e-05	0.00034	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN1B—uterine cancer	5.19e-05	0.000336	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—EP300—uterine cancer	5.09e-05	0.00033	CbGpPWpGaD
Bleomycin—Nausea—Doxorubicin—uterine cancer	5e-05	0.000538	CcSEcCtD
Bleomycin—LIG1—Disease—SMAD3—uterine cancer	4.8e-05	0.00031	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KRAS—uterine cancer	4.68e-05	0.000303	CbGpPWpGaD
Bleomycin—LIG1—Disease—FGFR2—uterine cancer	4.58e-05	0.000296	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—EP300—uterine cancer	4.56e-05	0.000295	CbGpPWpGaD
Bleomycin—LIG1—Disease—MTHFR—uterine cancer	4.4e-05	0.000285	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CA—uterine cancer	4.3e-05	0.000278	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HRAS—uterine cancer	3.98e-05	0.000257	CbGpPWpGaD
Bleomycin—BLMH—Immune System—AKT1—uterine cancer	3.51e-05	0.000227	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TP53—uterine cancer	3.26e-05	0.000211	CbGpPWpGaD
Bleomycin—LIG1—Disease—ERBB2—uterine cancer	2.87e-05	0.000186	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1B—uterine cancer	2.66e-05	0.000172	CbGpPWpGaD
Bleomycin—LIG1—Disease—CTNNB1—uterine cancer	2.51e-05	0.000163	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTEN—uterine cancer	2.45e-05	0.000158	CbGpPWpGaD
Bleomycin—LIG1—Disease—EP300—uterine cancer	2.34e-05	0.000151	CbGpPWpGaD
Bleomycin—LIG1—Disease—NRAS—uterine cancer	2.19e-05	0.000141	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—uterine cancer	1.88e-05	0.000122	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CA—uterine cancer	1.73e-05	0.000112	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—uterine cancer	1.6e-05	0.000103	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT1—uterine cancer	1.41e-05	9.13e-05	CbGpPWpGaD
